$ACB

Aurora Cannabis Acquires UK's Internode Pharma, HAP Pharma for $2.86 Million

Aurora Cannabis (ACB) agreed to acquire Internode Pharma and HAP Pharma for a combined 2.1 million British pounds ($2.86 million) to expand in the UK.Aurora, based in Edmonton, Canada, said Wednesday the price is contingent on certain post-closing conditions. Internode Pharma and HAP Pharma operate a licensed import and distribution facility and a virtual pharmacy in Birmingham, England.The acquisition is expected to be accretive to adjusted EBITDA in future quarters, helped by operational efficiencies and reduced reliance on third parties, Aurora said.Price: $3.86, Change: $+0.19, Percent Change: +5.18%

Update: Aurora Cannabis Shares Rise After Curaleaf Unveils Acquisition Proposal

(Updates with the latest stock price movement in the headline and the first paragraph.)Aurora Cannabis (ACB) shares rose 20.6% in Tuesday afternoon trading following Curaleaf's proposed acquisition of the company.Curaleaf disclosed Tuesday its plan to acquire Aurora Cannabis for an implied consideration of $4 per share, comprising 0.3463 Curaleaf share and $0.75 in cash.The proposed deal is expected to create a global cannabis platform with over $1.5 billion last 12 months revenue and nearly $350 million in adjusted EBITDA, with at least $40 million in annual cost synergies.No formal takeover bid has been commenced, Curaleaf said, adding that there is no assurance the proposed offer will ultimately be made.Price: $3.49, Change: $+0.60, Percent Change: +20.59%

Earnings Flash (ACB) Aurora Cannabis Inc. Reports Q1 Revenue C$67.6M, vs. FactSet Est of C$67.4M

Tilray Brands Says Cannabis Rescheduling Furthers Research, Access; Shares Rise Pre-Bell

Tilray Brands (TLRY) said Thursday that the Trump administration's move to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act furthers medical cannabis clinical research, patient access, and industry standardization.The rescheduling represents an inflection point for US drug policy, and Tilray will participate in the emerging regulated medical cannabis market in the country, the company said.Shares of Tilray Brands were up 14% in Thursday premarket trading.Other cannabis stocks like Canopy Growth (CGC), Cronos (CRON), High Tide (HITI), SNDL (SNDL), and Aurora Cannabis (ACB) were also higher following the news of cannabis rescheduling.